Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Funding boost for foot-and-mouth vaccine consortium
Foot-and-mouth is one of the most economically important infectious diseases of livestock across the world.
Investment marks the final step in bringing an affordable vaccine to market 

An international foot-and-mouth (FMD) vaccine research and development consortium has been awarded more than £3 million of funding from the Wellcome Trust to produce a more affordable and effective vaccine.

The consortium, led by The Pirbright Institute, will use the funding to build on initial research and answer remaining product development challenges. Welcoming the news, Dr Bryan Charleston of the Pirbright Institute said:

“This represents the final step in being able to bring an affordable and effective FMD vaccine to the market that does not require special facilities to produce, is less reliant on a cold chain, and so will transform the livelihood of those farmers in the poorest areas of the world who depend on their livestock for food and economic security.”

FMD is one of the most economically important infectious diseases of livestock across the world, affecting sheep, goats, pigs and other cloven-footed animals.

Initial research into a new vaccine to protect against the disease showed that virus-like particle (VLP) copies of FMD, grown in insect cells, were effective in protecting cattle against four serotypes of the disease. Researchers say the new research aims to translate these findings into a commercially viable vaccine that is effective against multiple strains of FMDV.

Consortium member Ian Jones, professor of virology at the University of Reading, said: “I am very grateful to the Wellcome Trust for their continued support of our research aimed at making vaccination against foot-and-mouth disease virus far more widespread. The basic science has progressed well but there is still a gap in making its manufacture a practical reality, which this funding should allow us to bridge.

“The principles we learn could also benefit other vaccines made in a similar way, for both animal and human disease.”

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.